Cited by 625Cell death mechanisms and regulationCancer-related Molecular PathwaysAutophagy in Disease and Therapy

The DOI matches its Crossref record; 182 of the 185 references it cites were found in a registry or an index.

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

Open access

Hata, Aaron N., Engelman, Jeffrey A., Faber, Anthony C.·2015·Cancer Discovery

DOI 10.1158/2159-8290.cd-15-0011PMC PMC4727530

Open this paper in CoChat — free account

Abstract

The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic apoptotic response. Recent advances in our understanding of apoptotic signaling pathways have enabled methods to identify cancers that are “primed” to undergo apoptosis, and have revealed potential biomarkers that may predict which cancers will undergo apoptosis in response to specific therapies. Complementary efforts have focused on developing novel drugs that directly target antiapoptotic BCL2 family proteins. In this review, we summarize the current knowledge of the role of BCL2 family members in cancer development and response to therapy, focusing on targeted therapeutics, recent progress in the development of apoptotic biomarkers, and therapeutic strategies designed to overcome deficiencies in apoptosis. Significance: Apoptosis, long known to be important for response to conventional cytotoxic chemotherapy, has more recently been shown to be essential for the efficacy of targeted therapies. Approaches that increase the likelihood of a cancer to undergo apoptosis following therapy may help improve targeted treatment strategies. Cancer Discov; 5(5); 475–87. ©2015 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-15-0011

Cites

182 of 182 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Cell Death
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477
Self-citation

Show all 185 references

Sorted by citations

Items 101–200 of 625

Phytol loaded PLGA nanoparticles ameliorate scopolamine-induced cognitive dysfunction by attenuating cholinesterase activity, oxidative stress and apoptosis in Wistar rat
Sathya, S., Manogari, B. G., Thamaraiselvi, K., Sethuraman, V., Kandasamy, R., & Devi, K. P. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1764290 · Cited by 55
The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression
Pan, Y., Zhang, Y., Chen, L., Liu, Y., Feng, Y., & Yan, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9378-9 · Cited by 55
Lactobacillus paracasei K5 displays adhesion, anti-proliferative activity and apoptotic effects in human colon cancer cells
Chondrou, P., Karapetsas, A., Kiousi, D. E., Tsela, D., Tiptiri-Kourpeti, A., Anestopoulos, I., Kotsianidis, Ι., Bezirtzoglou, E., Pappa, A., & Galanis, Α. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0183 · Cited by 55
Difenoconazole induces oxidative DNA damage and mitochondria mediated apoptosis in SH-SY5Y cells
Wang, X., Ni, H., Xu, W., Bing, W., Xie, T., Zhang, C., Cheng, J., Li, Z., Tao, L., & Zhang, Y. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131160 · Cited by 55
Characterization and anti-tumor activity of a polysaccharide isolated from Dendrobium officinale grown in the Huoshan County
Wei, Y., Wang, L., Wang, D., Wang, D., Wen, C., Han, B., & Ouyang, Z. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0205-x · Cited by 54
Homogeneous Oligomers of Pro-apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane Permeabilization
Hauseman, Z. J., Harvey, E. P., Newman, C. E., Wales, T. E., Bucci, J. C., Mintseris, J., Schweppe, D. K., David, L., Fan, L., Cohen, D. T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.029 · Cited by 66
Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives
Purohit, P., & Saini, N. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03670-0 · Cited by 40
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
Anderson, G. R., Wardell, S. E., Cakir, M., Crawford, L., Leeds, J. C., Nussbaum, D. P., Shankar, P. S., Soderquist, R. S., Stein, E. M., Tingley, J. P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0348 · Cited by 53
STAT3 pathway as a molecular target for resveratrol in breast cancer treatment
Kohandel, Z., Farkhondeh, T., Aschner, M., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02179-1 · Cited by 51
Structural characterization of an acid polysaccharide from Pinellia ternata and its induction effect on apoptosis of Hep G2 cells
Tian, W.-T., Zhang, X., Liu, H., Wen, Y., Li, H., & Gao, J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.219 · Cited by 52
Sub-ohm vaping increases the levels of carbonyls, is cytotoxic, and alters gene expression in human bronchial epithelial cells exposed at the air–liquid interface
Noël, A., Hossain, E., Perveen, Z., Zaman, H., & Penn, A. L. (2020) · Respiratory Research · doi:10.1186/s12931-020-01571-1 · Cited by 52
Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder
Wang, T. K., Xu, S., Li, S., & Zhang, Y. (2020) · Molecules · doi:10.3390/molecules25245971 · Cited by 52
CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5
Nengroo, M. A., Maheshwari, S., Singh, A., Verma, A., Arya, R. K., Chaturvedi, P., Saini, K. K., Singh, A. K., Sinha, A., Meena, S., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03730-8 · Cited by 49
Biosensors for Caspase-3: From chemical methodologies to biomedical applications
Lei, Q., Huang, X., Zheng, L., Zheng, F., Dong, J. N., Chen, F., & Zeng, W. (2022) · Talanta · doi:10.1016/j.talanta.2021.123198 · Cited by 50
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
Reck, M., Frost, N., Peters, S., Fox, B. A., Ferrara, R., Savai, R., & Barlési, F. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01061-7 · Cited by 62
BCL-W has a fundamental role in B cell survival and lymphomagenesis
Adams, C. M., Kim, A. S., Mitra, R., Choi, J. K., Gong, J. Z., & Eischen, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89486 · Cited by 51
NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
Liu, Y., Mondello, P., Erazo, T., Tannan, N. B., Asgari, Z., de Stanchina, E., Nanjangud, G. J., Seshan, V., Wang, S., Wendel, H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806928115 · Cited by 51
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
Iavarone, C., Zervantonakis, I. K., Selfors, L. M., Palakurthi, S. S., Liu, J. F., Drapkin, R., Matulonis, U. A., Hallberg, D. L., Velculescu, V. E., Leverson, J. D., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0413 · Cited by 52
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition
Nguyen, T. T. T., Ishida, C. T., Shang, E., Shu, C., Torrini, C., Zhang, Y., Bianchetti, E., Sanchez‐Quintero, M. J., Kleiner, G., Quinzii, C. M., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910769 · Cited by 51
PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation
Hu, G., Chen, Y., Xie, P., Cao, Y., Shao, J., & Ge, J. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112152 · Cited by 54
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells
Yang, M., Wang, L., Ni, M., Neuber, B., Wang, S., Gong, W., Sauer, T., Sellner, L., Schubert, M., Hückelhoven‐Krauss, A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608167 · Cited by 52
Molecular oncogenesis of chondrosarcoma: impact for targeted treatment
Speetjens, F. M., de Jong, Y., Gelderblom, H. A. J., & Bovée, J. V. M. G. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000300 · Cited by 50
MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation
Dong, Z., Qi, R., Guo, X., Zhao, X., Li, Y., Zeng, Z., Bai, W., Chang, X., Hao, L., Chen, Y., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.091 · Cited by 50
Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth
Kim, J. S., Turbov, J. M., Rosales, R., Thaete, L. G., & Rodriguez, G. C. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.05.022 · Cited by 50
Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells
Lucantoni, F., Lindner, A. U., O’Donovan, N., Düßmann, H., & Prehn, J. H. M. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0039-y · Cited by 51
Quercetin–Resveratrol Combination for Prostate Cancer Management in TRAMP Mice
Singh, C. K., Chhabra, G., Ndiaye, M. A., Siddiqui, I. A., Panackal, J. E., Mintie, C. A., & Ahmad, N. (2020) · Cancers · doi:10.3390/cancers12082141 · Cited by 49
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells
Ali, M., Lu, M., Ang, H. X., Soderquist, R. S., Eyler, C. E., Hutchinson, H. M., Glass, C., Bassil, C. F., Lopez, O. M., Kerr, D. L., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abc7480 · Cited by 52
Self-citation
Anti-tumor effect of polysaccharide from Hirsutella sinensis on human non-small cell lung cancer and nude mice through intrinsic mitochondrial pathway
Liu, W., Xie, F., Sun, H.-Q., Meng, M., & Zhu, Z. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.02.071 · Cited by 48
The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
Castelli, V., Giordano, A., Benedetti, E., Giansanti, F., Quintiliani, M., Cimini, A., & d’Angelo, M. (2021) · Cancers · doi:10.3390/cancers13020328 · Cited by 47
Transcriptomic analysis of gingival mesenchymal stem cells cultured on 3 D bioprinted scaffold: A promising strategy for neuroregeneration
Gugliandolo, A., Diomede, F., Cardelli, P., Bramanti, A., Scionti, D., Bramanti, P., Trubiani, O., & Mazzon, E. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36213 · Cited by 47
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 55
Characterization and antitumor activity of novel exopolysaccharide APS of Lactobacillus plantarum WLPL09 from human breast milk
Jiang, B., Tian, L., Huang, X., Liu, Z., Jia, K., Wei, H., & Tao, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.277 · Cited by 47
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
Vinhas, R., Fernandes, A. R., & Baptista, P. V. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.05.003 · Cited by 46
Expressed fusion gene landscape and its impact in multiple myeloma
Cleynen, A., Szalat, R. E., Samur, M., Robiou-du-Pont, S., Buisson, L., Boyle, E. M., Chrétien, M., Anderson, K. C., Minvielle, S., Moreau, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00638-w · Cited by 50
Nodal Facilitates Differentiation of Fibroblasts to Cancer-Associated Fibroblasts that Support Tumor Growth in Melanoma and Colorectal Cancer
Li, Z., Zhang, J., Zhou, J., Lu, L., Wang, H., Zhang, G., Wan, G., Cai, S., & Du, J. (2019) · Cells · doi:10.3390/cells8060538 · Cited by 46
TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
Zeinabad, H. A., & Szegezdi, É. (2022) · Cancers · doi:10.3390/cancers14205125 · Cited by 47
Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway
Zhu, B., & Wei, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2719 · Cited by 45
Antitumor Activity of Ohmyungsamycin A through the Regulation of the Skp2-p27 Axis and MCM4 in Human Colorectal Cancer Cells
Byun, W. S., Kim, S., Shin, Y., Kim, W. K., Oh, D., & Lee, S. K. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00918 · Cited by 45
miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
Samuel, P., Pink, R. C., Brooks, S. A., & Carter, D. R. F. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1121107 · Cited by 44
Apoptotic effect of noscapine in breast cancer cell lines
Quisbert-Valenzuela, E. O., & Calaf, G. M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3476 · Cited by 45
Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1
You, W., Chen, B., Liu, X., Xue, S., Qin, H., & Jiang, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-00698-4 · Cited by 44
The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
Svahn, N., Moro, A. J., Roma‐Rodrigues, C., Puttreddy, R., Rissanen, K. T., Baptista, P. V., Fernandes, A. R., Lima, J. C., & Rodrı́guez, L. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802547 · Cited by 44
miRNA Modulation and Antitumor Activity by the Extra-Virgin Olive Oil Polyphenol Oleacein in Human Melanoma Cells
Carpi, S., Polini, B., Manera, C., Digiacomo, M., Salsano, J. E., Macchia, M., Scoditti, E., & Nieri, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.574317 · Cited by 44
Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth
Cui, H., Wu, S., Shang, Y., Li, Z., Chen, M., Li, F., & Wang, C. (2016) · Food & Function · doi:10.1039/c6fo00027d · Cited by 44
c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors
Liu, H., Ai, J., Shen, A., Chen, Y., Wang, X., Xia, P., Chen, H., Shen, Y., Huang, M., Ding, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2448 · Cited by 43
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263
Huang, T., Ding, X., Xu, G., Chen, G., Cao, Y. Q., Peng, C., Shen, S., Lv, Y., Wang, L., & Zou, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1831-7 · Cited by 43
Drug Resistance and its Clinical Circumvention
Moscow, J. A., Cowan, K. H., & Sikic, B. I. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm063 · Cited by 43
Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer
Li, H., Liu, L., Chang, H., Zou, Z., & Xing, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0169-2 · Cited by 43
MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1)
Zhu, Y., Wen, X., & Zhao, P. (2018) · Medical Science Monitor · doi:10.12659/msm.909633 · Cited by 41
IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo
Guntuku, L., Gangasani, J. K., Thummuri, D., Borkar, R. M., Manavathi, B., Srinivas, R., Vaidya, J. R., Sistla, R., & Naidu, V. G. M. (2018) · Oncogene · doi:10.1038/s41388-018-0446-2 · Cited by 42
Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
Jin, B., & An, H. (2020) · Aging · doi:10.18632/aging.102731 · Cited by 43
Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling
Al-Obeed, O. A., El‐Obeid, A., Matou‐Nasri, S., Vaali‐Mohammed, M., Alhaidan, Y., Elwatidy, M., Dosary, H. A., Alehaideb, Z., Al‐Khayal, K., Haseeb, A., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01206-x · Cited by 44
Resistance to drugs and cell death in cancer stem cells (CSCs)
Safa, A. R. (2020) · Journal of Translational Science · doi:10.15761/jts.1000341 · Cited by 50
Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA
Subramanian, A., Andronache, A., Li, Y., & Wade, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.7558 · Cited by 38
Comparative transcriptomics of elasmobranchs and teleosts highlight important processes in adaptive immunity and regional endothermy
Marra, N. J., Richards, V. P., Early, A. M., Bogdanowicz, S. M., Bitar, P. D. P., Stanhope, M. J., & Shivji, M. S. (2017) · BMC Genomics · doi:10.1186/s12864-016-3411-x · Cited by 42
BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma
Ishida, C. T., Bianchetti, E., Shu, C., Halatsch, M., Westhoff, M., Karpel‐Massler, G., & Siegelin, M. D. (2017) · Oncotarget · doi:10.18632/oncotarget.16365 · Cited by 41
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
Nougarède, A., Popgeorgiev, N., Kassem, L. M. H., Omarjee, S., Borel, S., Mikaélian, I., Lopez, J., Gadet, R., Marcillat, O., Treilleux, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-0846 · Cited by 41
The potential protective and therapeutic effects of platelet-rich plasma on ischemia/reperfusion injury following experimental torsion/detorsion of testis in the Albino rat model
Samy, A., El‐Adl, M., Rezk, S., Marghani, B. H., Eldomany, W., Eldesoky, A., & Elmetwally, M. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117982 · Cited by 41
Virtual screening, SAR , and discovery of 5‐(indole‐3‐yl)‐2‐[(2‐nitrophenyl)amino] [1,3,4]‐oxadiazole as a novel Bcl‐2 inhibitor
Ziedan, N. I., Hamdy, R., Cavaliere, A., Kourti, M., Prencipe, F., Brancale, A., Jones, A. T., & Westwell, A. D. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12936 · Cited by 40
Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells
Moghadam, A. R., Rosa, S. C. D. S., Samiei, E., Alizadeh, J., Field, J. T., Kawalec, P., Thliveris, J. A., Akbari, M., Ghavami, S., & Gordon, J. W. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0115-9 · Cited by 41
A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway
Dabiri, Y., Schmid, A. K., Theobald, J., Blagojevic, B., Streciwilk, W., Ott, I., Wölfl, S., & Cheng, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123964 · Cited by 39
Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types
Ben‐Hamo, R., Zilberberg, A., Cohen, H., Bahar‐Shany, K., Wachtel, C., Korach, J., Aviel‐Ronen, S., Barshack, I., Barash, D., Levanon, K., et al. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0084-3 · Cited by 40
Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
Mu, H., Zhu, X., Jia, H., Zhou, L., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643382 · Cited by 40
A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
Abolfathi, H., Arabi, M., & Sheikhpour, M. (2023) · Respiratory Research · doi:10.1186/s12931-023-02366-w · Cited by 43
Chronic heat stress negatively affects the immune functions of both spleens and intestinal mucosal system in pigs through the inhibition of apoptosis
Huo, C., Xiao, C., She, R., Liu, T., Tian, J., Dong, H., Tian, H., & Hu, Y. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103672 · Cited by 39
microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis
Rezaei, T., Hejazi, M., Mansoori, B., Mohammadi, A., Amini, M. A., Mosafer, J., Rezaei, S., Mokhtarzadeh, A., & Baradaran, B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173483 · Cited by 41
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges
Zhang, Z., Hou, L., Liu, D., Luan, S., Huang, M., & Zhao, L. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.02.010 · Cited by 42
The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
Heisey, D. A. R., Lochmann, T. L., Floros, K. V., Coon, C. M., Powell, K. M., Jacob, S., Calbert, M. L., Ghotra, M. S., Stein, G. T., Maves, Y. K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0277 · Cited by 35
Self-citation
Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer
Xu, D., Li, Q., Hu, H., Ni, B., Liu, X., Huang, C., Zhang, Z., & Zhao, G. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0974-1 · Cited by 38
Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer Treatment
Zhou, Q., Pan, H., & Li, J. (2019) · Cancers · doi:10.3390/cancers11101565 · Cited by 38
ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis
Tan, H., Wang, N., Chan, Y.-T., Zhang, C., Guo, W., Chen, F., Zhong, Z., Li, S., & Feng, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.025 · Cited by 38
Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer
Léonce, C., Saintigny, P., & Ortiz‐Cuaran, S. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0038 · Cited by 41
Anticancer effects and mechanisms of astragaloside‑IV (Review)
Zhou, L., Li, M., Chai, Z., Zhang, J., Cao, K., Deng, L., Liu, Y., Jiao, C., Zou, G.-M., Wu, J., et al. (2022) · Oncology Reports · doi:10.3892/or.2022.8442 · Cited by 43
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression
Kotani, H., Ebi, H., Kitai, H., Nanjo, S., Kita, K., Huynh, T. G., Ooi, A., Faber, A. C., Mino-Kenudson, M. A., & Yano, S. (2015) · Oncogene · doi:10.1038/onc.2015.426 · Cited by 38
Self-citation
Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
Kamaruzman, N. I., Abd-Aziz, N., Poh, C. L., & Chowdhury, E. H. (2019) · Cancers · doi:10.3390/cancers11050632 · Cited by 37
Garlic-derived bioactive compound S-allylcysteine inhibits cancer progression through diverse molecular mechanisms
Agbana, Y. L., Ni, Y., Zhou, M., Zhang, Q., Kassegne, K., Karou, S. D., Kuang, Y., & Zhu, Y. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.11.002 · Cited by 38
Molecular docking study of naturally derived flavonoids with antiapoptotic BCL-2 and BCL-XL proteins toward ovarian cancer treatment
Nordin, N., Ghani, M. F. A., & Othman, R. (2020) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_272_19 · Cited by 37
Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models
Amin, A. R. M. R., Wang, D., Nannapaneni, S., Lamichhane, R., Chen, Z., & Shin, D. (2021) · Oncology Reports · doi:10.3892/or.2021.8038 · Cited by 37
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF
Konda, J. D., Olivero, M., Musiani, D., Lamba, S., & Renzo, M. F. D. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12042 · Cited by 36
DNMTs inhibitor SGI‑1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells
Sun, N., Zhang, J., Zhang, C., Zhao, B., & Jiao, A. (2018) · Oncology Letters · doi:10.3892/ol.2018.9390 · Cited by 36
Overexpression and biological function of PRDX6 in human cervical cancer
Hu, X., Lu, E., Pan, C., Xu, Y., & Zhu, X. (2020) · Journal of Cancer · doi:10.7150/jca.39892 · Cited by 36
Combination Therapy with Cinnamaldehyde and Hyperthermia Induces Apoptosis of A549 Non-Small Cell Lung Carcinoma Cells via Regulation of Reactive Oxygen Species and Mitogen-Activated Protein Kinase Family
Park, J., & Baek, S. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176229 · Cited by 38
The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer
Carberry, S., D’Orsi, B., Monsefi, N., Salvucci, M., Bacon, O., Fay, J., Rehm, M., McNamara, D. A., Kay, E. W., & Prehn, J. H. M. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0140-2 · Cited by 35
The chemical biology of apoptosis: Revisited after 17 years
Yang, S., Mao, Y., Zhang, H., Xu, Y., An, J., & Huang, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.019 · Cited by 35
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
Lin, W., Sun, J., Sadahira, T., Xu, N., Wada, K., Liu, C., Araki, M., Xu, A., Watanabe, M., Nasu, Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63125 · Cited by 35
RETRACTED: Orientin, a Bio-Flavonoid from Trigonella hamosa L., Regulates COX-2/PGE-2 in A549 Cell Lines via miR-26b and miR-146a
Khalil, H. E., Ibrahim, H.-I. M., Ahmed, E. A., Emeka, P. M., & Alhaider, I. A. (2022) · Pharmaceuticals · doi:10.3390/ph15020154 · Cited by 36
Retracted
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
Jantz-Naeem, N., Loschinski, R., Borucki, K., Mitchell-Flack, M., Böttcher, M., Schraven, B. L., Mougiakakos, D., & Kahlfuß, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1060112 · Cited by 37
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
de Jong, Y., van Maldegem, A. M., Mariño‐Enríquez, A., de Jong, D., Suijker, J., Bruijn, I. H. B., Kruisselbrink, A. B., Cleton-Jansen, A., Szuhai, K., Gelderblom, H. A. J., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.91 · Cited by 34
The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells
Schneider, D., Chua, R. L., Molitor, N., Hamdan, F. H., Rettenmeier, E., Prokakis, E., Mishra, V. K., Kari, V., Wegwitz, F., Johnsen, S. A., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0698-x · Cited by 36
MicroRNA dysregulation and multi-targeted therapy for cancer treatment
Balatti, V., & Croce, C. M. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.100669 · Cited by 34
Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma
Huang, L., Wang, Y., Bai, J., Yang, Y., Wang, F., Feng, Y., Zhang, R., Li, F., Zhang, P., Lv, N., et al. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01078-0 · Cited by 34
Effects of nuclear respiratory factor‑1 on apoptosis and mitochondrial dysfunction induced by cobalt chloride in H9C2 cells
Niu, N., Li, Z., Zhu, M., Sun, H., Yang, J., Xu, S., Zhao, W., & Song, R. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9839 · Cited by 33
Zinc oxide nanoparticles induce necroptosis and inhibit autophagy in MCF-7 human breast cancer cells
Farasat, M., Niazvand, F., & Khorsandi, L. (2019) · Biologia · doi:10.2478/s11756-019-00325-9 · Cited by 33
The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
Dou, Y., Jiang, X., Xie, H., He, J., & Xiao, S. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0573-6 · Cited by 33
Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
Çoku, J., Booth, D. M., Skoda, J., Pedrotty, M. C., Vogel, J., Liu, K., Vu, A. T., Carpenter, E. L., Ye, J. C., Chen, M. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108272 · Cited by 31
Sesquiterpene Alcohol Cedrol Chemosensitizes Human Cancer Cells and Suppresses Cell Proliferation by Destabilizing Plasma Membrane Lipid Rafts
Mishra, S. K., Bae, Y. S., Lee, Y.-M., Js, K., Oh, S. H., & Kim, H. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.571676 · Cited by 33
Continuous ZnO nanoparticle exposure induces melanoma-like skin lesions in epidermal barrier dysfunction model mice through anti-apoptotic effects mediated by the oxidative stress–activated NF-κB pathway
Wang, P., Hu, G., Zhao, W., Du, J., You, M., Xv, M., Yang, H. Y., Zhang, M., Yan, F., Huang, M., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01308-w · Cited by 33
Role of USP13 in physiology and diseases
Wang, Q., Sun, Z., Xia, W., Sun, L., Du, Y., Zhang, Y., & Jia, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.977122 · Cited by 32
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
Spinner, S., Crispatzu, G., Yi, J.-H., Munkhbaatar, E., Mayer, P., Höckendorf, U., Müller, N., Li, Z., Schader, T., Bendz, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.49 · Cited by 32
High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells
Horn, T. L., Ferretti, S., Ebel, N., Tam, A., Ho, S. B., Harbinski, F., Farsidjani, A., Zubrowski, M. J., Sellers, W. R., Schlegel, R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3425 · Cited by 33

Authors: Hata, A. N., Engelman, J. A., & Faber, A. C.
Affiliations: Harvard University (US)
Virginia Commonwealth University (US)
Corresponding author: Engelman, Jeffrey A.
Faber, Anthony C.
ORCID: Hata, Aaron N.
Engelman, Jeffrey A.
Faber, Anthony C.
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2015-05-01
Volume: 5
Issue: 5
Pages: 475-487
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-15-0011
PMC: PMC4727530
OpenAlex: W2067275727
Cited by: 619
References: 185
Citations by year: 2026: 19 · 2025: 48 · 2024: 46 · 2023: 42 · 2022: 69 · 2021: 79 · 2020: 83 · 2019: 79 · 2018: 73 · 2017: 45 · 2016: 29 · 2015: 6
FWCI: 4.94
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Discovery (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P50CA127003, R01CA140594, R01CA164273, R01CA137008)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: Bcl-2 family proteins, apoptosis, targeted cancer therapy, mitochondrial apoptosis, cancer therapy response, carcinogenesis, apoptosis resistance
MeSH terms: Bcl-2-Like Protein 11, Animals, Antineoplastic Agents, Humans, Membrane Proteins, Neoplasms, Proto-Oncogene Proteins, Signal Transduction, Biomarkers, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks